Anti-tie2 antibodies and uses thereof

PK201200547A0Undetermined Publication Date: 2012-09-26REGENERON PHARMACEUTICALS INC

Patent Information

Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
REGENERON PHARMACEUTICALS INC
Filing Date
2012-08-16
Publication Date
2012-09-26
Patent Text Reader

Abstract

The present invention provides antibody that specifically binds human Tie2 (tyrosine kinase receptor) and block the interaction between Tie2 and one or more Tie2 ligands such as angiopoietin 1 (Angl), angiopoietin 2 (Ang2), angiopoietin 3 (Ang3) and / or angiopoietin 4 (Ang4). The present invention further provides a pharmaceutical composition comprising the said antibody along with pharmaceutical acceptable carrier or diluent. The antibody of the invention is useful, inter alia, for the treatment of diseases and disorders associated with one or more Tie2 biological activities including angiogenesis.
Need to check novelty before this filing date? Find Prior Art